Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE1, PHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Pancreatic Ductal Adenocarcinoma
Locations
- Seoul National University Bundang Hospital, Gyeonggi-do, South Korea
- Samsung Medical Center, Seoul, South Korea
- Seoul national university hospital, Seoul, South Korea
- Severance Hospital, Seoul, South Korea